Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2016

View Archived Issues

Neurospecific gene therapy improves cognition in Down syndrome model

Mitsubishi Tanabe Pharma offers overview of fourth quarter of fiscal 2015

HTG Molecular Diagnostics enters research collaboration agreement with BMS

Phenomenome Discoveries validates OvAware blood test for early detection of ovarian cancer

Leica Biosystems to collaborate with UCLA on digital pathology

Researchers present novel biomarker discoveries in pediatric diseases

FDA grants fast track designation to Edge Therapeutics' EG-1962

GlaxoSmithKline patents EZH2 inhibitors

Ziarco reports topline results from phase IIa study of ZPL-389 in atopic dermatitis

AbbVie patents reveal CFTR channel correctors

ApoGlyx describes AQP-9 inhibitors

Bristol-Myers Squibb reports development of BTK inhibitors

Prima BioMed and Sydys enter licensing agreement to advance CVac program

CellCept approved in Japan for lupus nephritis

Baxdela meets the primary endpoints in confirmatory phase III study

Mundipharma and Purdue Pharma take over responsibility for development of E-52862

Janssen Pharmaceutica presents RORgammaT modulators

Serendex and Nobelpharma sign Japanese license agreement for Molgradex

Mylan announces agreement to acquire Renaissance's topicals business

Scynexis' SCY-078 receives FDA orphan drug designation

Pfizer set to acquire Anacor Pharmaceuticals

Novel small molecule shows promise for the treatment of retinal disease

Thermo Fisher Scientific obtains FDA clearance for Elia anti-TG and anti-TPO tests

Antitumor immune responses seen with TNFSF18 fusion protein GITRL-Fc

Crown Bioscience establishes NSCLC PDX models with non-canonical EGFR mutations

WHO issues new recommendations on rapid detection and shorter treatment regimen for MDR-TB

Bayer Yakuhin launches Ventavis inhalation solution

AstraZeneca announces positive phase III results for benralizumab in severe asthma

New pan-RAF and VEGFR-2 dual inhibitor blocks tumor growth in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...